BiotechTube
Home/Pipeline/PB103

PB103

Not Specified

Pre-clinicalActive

Key Facts

Indication
Not Specified
Phase
Pre-clinical
Status
Active
Company
Pure Biologics

About Pure Biologics

Pure Biologics is a publicly traded biotech company based in Poland, specializing in the development of novel antibody and aptamer-based therapeutics for immuno-oncology. It has built a proprietary technology platform for selecting active molecules and has progressed two lead candidates, PB004 and PB003G, into Phase 0 clinical studies with FDA approvals. The company's strategy is to achieve financial independence by commercializing its therapeutic candidates to fund further advanced R&D projects.

View full company profile

Therapeutic Areas

OncologyImmuno-oncology

Other Not Specified Drugs

DrugCompanyPhase
FL116Forlong BiotechnologyNot specified
FL117Forlong BiotechnologyNot specified
FL118Forlong BiotechnologyNot specified
FL301Forlong BiotechnologyNot specified
JSKN016AlphaMab OncologyPhase 1
JSKN033AlphaMab OncologyPhase 1
JSKN022AlphaMab OncologyPhase 1
JSKN027AlphaMab OncologyPhase 1
KN019AlphaMab OncologyPhase 1
New TCM FormulationsChina SXT PharmaceuticalsResearch / Pre-clinical
Long-acting LeronlimabCytoDynPreclinical
SR2162SIMR (Australia) BiotechIND Approved